PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Actinium Pharmaceuticals, Inc. (ATNM)
1.780.01 (-0.56%)
1.75 - 1.81
1.03 - 2.41
122.5K / 296.7K (Avg.)
-1.36 | -1.31
Gauges a company's environmental, social, and governance practices.
46.92
ESG score 80-90% of VKTX's 56.58. Walter Schloss would scrutinize governance quality and regulatory exposure.
27.98
Environmental score below 80% of VKTX's 48.96. Jim Chanos would check for potential stranded asset risks and carbon liabilities.
55.48
Social score 90-95% of VKTX's 60.46. Bill Ackman would demand clear social improvement catalysts.
57.30
Similar governance score to VKTX's 60.31. Bruce Berkowitz would investigate if industry governance norms adequately protect shareholder value.